Back to Citadel Advisors LLC Citadel Advisors LLC

RDHL

5 quarters

Position history for Citadel Advisors LLCCitadel Advisors LLC's holdings in Redhill Biopharma Ltd.

Yes. Citadel Advisors holds 65,321 shares of RDHL (Redhill Biopharma), worth $55,196, as of its Q2 2026 13F filing. It increased the position from 20,673 shares in Q1 2026. Citadel Advisors has held RDHL since Q4 2025, across 3 quarterly 13F filings.

Current Value

$55,196

Current Shares

65,321

Total Value Change

-$2,026

Total Shares Change

+43,809

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
65,321
+216.0%
$55,1960.0%$0.85
23
2026-Q1
Increased
20,673
+33.6%
$15,4060.0%$0.75
16
2025-Q4
New
15,477
-
$15,9410.0%$1.03
28
2025-Q2
Exited
0
-100.0%
$00.0%$1.94
0
2025-Q1
New
21,512
-
$57,2220.0%$2.66
32

Other major holders of RDHL: Fédération des caisses Desjardins du Québec, UBS Group AG, Morgan Stanley

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used